healthprotocol.wiki

Protocols Evidence Outcomes

medication-migraine-prevention-fremanezumab-subcutaneous-quarterly-generic

Outcomes

01
pain-headache-migraine-monthly-headache-hours-any-severity-change-self-reported
1 evidence row
- ashina-m_2021_rct_reduction-in-the-severity-and-duration-of-headache-following-fremanezumab-treatment-in-patients-with-episodic-and-chronic-migraine
02
pain-headache-migraine-monthly-moderate-to-severe-headache-days-percent-decrease-self-reported
1 evidence row
- ashina-m_2021_rct_reduction-in-the-severity-and-duration-of-headache-following-fremanezumab-treatment-in-patients-with-episodic-and-chronic-migraine
03
pain-headache-migraine-monthly-moderate-to-severe-headache-hours-change-self-reported
1 evidence row
- ashina-m_2021_rct_reduction-in-the-severity-and-duration-of-headache-following-fremanezumab-treatment-in-patients-with-episodic-and-chronic-migraine
04
pain-headache-migraine-pain-severity-peak-change-numeric-rating-scale-self-reported
1 evidence row
- ashina-m_2021_rct_reduction-in-the-severity-and-duration-of-headache-following-fremanezumab-treatment-in-patients-with-episodic-and-chronic-migraine

Evidence

1rows

On this page

Permalink

/protocols/medication-migraine-prevention-fremanezumab-subcutaneous-quarterly-generic

healthprotocol.wiki

A community-driven, evidence-based health registry. Built for transparency.